XML 32 R24.htm IDEA: XBRL DOCUMENT v3.22.1
SHARE-BASED COMPENSATION AND WARRANTS (Tables)
9 Months Ended
Mar. 31, 2022
SHARE-BASED COMPENSATION AND WARRANTS  
Schedule of the Number of Shares Authorized, Outstanding, and Available for Future Grants Under Stock Option

Presented below is a summary of the number of shares authorized, outstanding, and available for future grants under each of the Company’s stock option plans as of March 31, 2022 (in thousands):

​

​

​

​

​

​

​

​

​

​

​

    

Plan Termination

    

Number of Shares

Description

    

Date

    

Authorized

    

Outstanding

    

Available

2015 Plan

 

February 2020

 

45

 

45

 

—

2016 Plan

 

October 2021

 

260

 

260

 

—

2019 Plan

 

July 2029

 

200

 

200

 

—

2021 Plan

​

March 2030

​

1,200

​

1,082

​

118

Total

 

  

 

1,705

 

1,587

 

118

Summary of the Stock Option Activity

The following table sets forth a summary of the activity under all of the Company’s stock option plans for the nine months ended March 31, 2022 (shares in thousands):

​

​

​

​

​

​

​

​

​

    

Shares

    

Price (1)

    

Term (2)

Outstanding, June 30, 2021

 

1,285

​

$

16.35

 

8.7

Granted

​

421

​

​

5.37

​

​

Expired

​

(61)

​

​

20.19

​

​

Forfeited

​

(58)

​

​

10.28

​

​

Outstanding, March 31, 2022

 

1,587

​

 

13.41

 

8.6

Vested, March 31, 2022

 

620

​

 

19.23

 

7.5

(1)Represents the weighted average exercise price.
(2)Represents the weighted average remaining contractual term for the number of years until the stock options expire.
Schedule of the Fair Value of Stock Options was Estimated on the Date of Grant Using the BSM Option-Pricing Model Using following Weighted-Average Assumptions

​

​

​

​

​

​

Market price of common stock on grant date

​

$

4.09

​

Expected volatility

    

​

94

%

Risk free interest rate

 

​

1.8

%

Expected term (years)

 

​

6.1

​

Dividend yield

 

​

0

%

Schedule of Share-Based Compensation Expense

Share-based compensation expense for the three and nine months ended March 31, 2022 and 2021 is included under the following captions in the unaudited condensed consolidated statements of operations (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

Three Months Ended

​

Nine Months Ended

​

​

​

March 31, 

​

March 31, 

​

​

    

2022

    

2021

​

2022

    

2021

​

Research and development

​

$

327

​

$

284

​

$

1,014

​

$

1,098

​

General and administrative

​

 

523

​

 

246

​

 

1,687

​

 

1,207

​

Total

​

$

850

​

$

530

​

$

2,701

​

$

2,305

​

Schedule of Warrant Activity

In addition, the Company has issued warrants in conjunction with various debt and equity financings and for services. The following table sets forth a summary of the warrant activity (excluding the 2021 PFWs) for the nine months ended March 31, 2022 (shares in thousands):

​

​

​

​

​

​

​

​

​

​

    

Shares

    

Price (1)

    

Term (2)

Outstanding, beginning of period

 

1,252

  

$

28.91

 

4.8

Warrant expirations

 

(94)

  

 

95.79

 

  

Outstanding, end of period

 

1,158

  

 

23.45

 

4.4

(1)Represents the weighted average exercise price.
(2)Represents the weighted average remaining contractual term for the number of years until the warrants expire.